Clinical Edge Journal Scan

Preoperative vitamin D levels may influence outcomes in patients with localized CRC undergoing resection


 

Key clinical point: Higher preoperative vitamin D levels were associated with lower odds of a complicated surgical course in older patients with colorectal cancer (CRC) undergoing resection, with deficient preoperative vitamin D levels being associated with poor overall survival irrespective of age.

Major finding: Higher vitamin D levels prior to resection were associated with a reduced risk for major complications after surgery in patients aged 70 years (odd ratio 0.51; 95% CI 0.27-0.95) but not in those aged <70 years, with deficient (<25 nmol/L) vs sufficient (>50 nmol/L) levels of vitamin D being associated with reduced survival irrespective of age (hazard ratio 3.39; P = .019).

Study details : Findings are from an ongoing prospective cohort study including 398 patients with stage I-III CRC who underwent surgical resection, of which 208 patients were aged ≥70 years.

Disclosures: This study was funded by the VELUX Foundation, Denmark, and the Beckett Foundation, Denmark . The authors declared no competing financial interests.

Source: Dolin TG et al. Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival. Eur J Surg Oncol. 2022 (Sep 10). Doi: 10.1016/j.ejso.2022.08.040

Recommended Reading

Colonoscopy in FIT-based screening demands higher ADR
MDedge Hematology and Oncology
Colonoscopy lowers CRC risk and death, but not by much: NordICC
MDedge Hematology and Oncology
Sigmoidoscopy screening cuts CRC mortality, incidence
MDedge Hematology and Oncology
One-third of pancreatic cancer diagnoses missed on scans
MDedge Hematology and Oncology
Low rectal cancer: Laparoscopic-assisted surgery safe in terms of short-term oncological outcomes
MDedge Hematology and Oncology
Benefits of simultaneous resection of liver metastasis restricted to patients with KRAS wild-type tumors
MDedge Hematology and Oncology
Long-term use of antihypertensive drugs and CRC risk: Is there a link?
MDedge Hematology and Oncology
Longer interval between nCRT and surgery increases tumor regression in LARC
MDedge Hematology and Oncology
Capecitabine consolidation chemotherapy after NCRT improves CR in LARC
MDedge Hematology and Oncology
Special CRC prevention efforts may focus on population with higher serum uric acid levels
MDedge Hematology and Oncology